Weber C, Springer T A
The Center for Blood Research and Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA.
J Clin Invest. 1997 Oct 15;100(8):2085-93. doi: 10.1172/JCI119742.
We have studied the pathways that lead to arrest and firm adhesion of rolling PMN on activated, surface-adherent platelets. Stable arrest and adhesion strengthening of PMN on thrombin-stimulated, surface-adherent platelets in flow required distinct Ca2+- and Mg2+-dependent regions of Mac-1 (alphaMbeta2), and involved interactions of Mac-1 with fibrinogen, which was bound to platelets via alphaIIbbeta3. Mac-1 also bound to other unidentified ligands on platelets, which were not intracellular adhesion molecule-2 (ICAM-2), heparin, or heparan-sulfate proteoglycans. This was shown by inhibition with mAbs or peptides, by treatment of platelets with heparitinase, and by using platelets with defective alphaIIbbeta3 from a patient with Glanzmann thrombasthenia. Tethering of PMN on platelet ICAM-2 via LFA-1 (alphaLbeta2) was observed, which may facilitate the transition between rolling on selectins and Mac-1-dependent arrest. Arrest and adhesion strengthening was pertussis toxin sensitive and in flow was mainly induced by platelet-activating factor but not through activation of the chemokine receptor CXCR2. In stasis, spreading occurred and the CXCR2 contributed to firm adhesion.
我们研究了导致滚动的中性粒细胞在活化的、表面黏附的血小板上停滞并牢固黏附的途径。在流动状态下,中性粒细胞在凝血酶刺激的、表面黏附的血小板上的稳定停滞和黏附增强需要Mac-1(αMβ2)的不同钙依赖和镁依赖区域,并涉及Mac-1与纤维蛋白原的相互作用,纤维蛋白原通过αIIbβ3与血小板结合。Mac-1还与血小板上其他未鉴定的配体结合,这些配体不是细胞间黏附分子-2(ICAM-2)、肝素或硫酸乙酰肝素蛋白聚糖。这通过单克隆抗体或肽的抑制、用肝素酶处理血小板以及使用来自一名患有Glanzmann血小板无力症患者的αIIbβ3缺陷血小板得以证明。观察到中性粒细胞通过LFA-1(αLβ2)与血小板ICAM-2结合,这可能有助于在选择素上滚动与Mac-1依赖的停滞之间的转变。停滞和黏附增强对百日咳毒素敏感,在流动状态下主要由血小板活化因子诱导,而非通过趋化因子受体CXCR2的激活。在静态条件下,会发生铺展,CXCR2有助于牢固黏附。